Article
Patient-Reported Outcomes of Azelaic Acid Foam 15% for Patients With Papulopustular Rosacea: Secondary Efficacy Results From a Randomized, Controlled, Double-blind, Phase 3 Trial
- Author:
- Stephen Tyring, MD, PhD
- James A. Solomon, MD, PhD
- Gerald Staedtler, MSc
- Jason P. Lott, MD, MSHP, MHS
- Richard Nkulikiyinka, MD
- Kaweh Shakery, MD
Patient-reported treatment outcomes are important for evaluating the impact of drug therapies on patient experience. A randomized, double-blind,...
Article
Investigator-Reported Efficacy of Azelaic Acid Foam 15% in Patients With Papulopustular Rosacea: Secondary Efficacy Outcomes From a Randomized, Controlled, Double-blind, Phase 3 Trial
- Author:
- James A. Solomon, MD, PhD
- Stephen Tyring, MD, PhD
- Gerald Staedtler, MSc
- Meike Sand, MSc
- Richard Nkulikiyinka, MD
- Kaweh Shakery, MD
Papulopustular rosacea (PPR) is characterized by centrofacial papules and pustules commonly associated with erythema. To compare investigator-...
Article
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea: A Randomized, Double-blind, Vehicle-Controlled Study
- Author:
- Zoe Diana Draelos, MD
- Boni Elewski, MD
- Gerald Staedtler, MSc
- Blanka Havlickova, MD, PhD
Rosacea is a common chronic inflammatory skin disease that primarily affects facial skin. Its etiology is unknown, and currently there is no cure...